MedPage Today January 9, 2026
Move will require insurers to cover self-collected samples for HPV testing without cost-sharing
New federal guidelines from the Health Resources and Services Administration (HRSA) now include the option for women ages 30 to 65 years at average risk for cervical cancer to self-collect samples for screening.
The move means that starting in 2027, most private insurers will be required to cover self-collected human papillomavirus (HPV) testing and any necessary follow-up tests without cost-sharing.
“If additional testing (e.g., cytology, biopsy, colposcopy, extended genotyping, dual stain) and pathologic evaluation are indicated, these services also are recommended to complete the screening process for malignancies,” the updated guideline from the HRSA-funded Women’s Preventive Services Initiative states.
The guideline designates HPV testing as the preferred...
Today's Sponsors
Today's Sponsor